Logos Global Management LP cut its holdings in Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) by 47.7% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 750,000 shares of the company’s stock after selling 685,000 shares during the period. Bicycle Therapeutics comprises approximately 2.3% of Logos Global […]
Logos Global Management LP boosted its position in MorphoSys AG (NASDAQ:MOR – Free Report) by 66.7% in the 1st quarter, Holdings Channel reports. The firm owned 1,500,000 shares of the company’s stock after buying an additional 600,000 shares during the quarter. Logos Global Management LP’s holdings in MorphoSys were worth $5,940,000 at the end of […]
Logos Global Management LP lessened its stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 16.7% in the first quarter, HoldingsChannel.com reports. The firm owned 50,000 shares of the biopharmaceutical company’s stock after selling 10,000 shares during the quarter. Madrigal Pharmaceuticals accounts for 1.7% of Logos Global Management LP’s portfolio, making the stock its […]